CEO and CFO sold their shares first time in 10 years!
CEO preplanned his sale back in August. He had no knowledge of the price or whether Senhace will get FDA approval.
Both of them put their own money last year. Bought at almost $2 per share. Just look at Nasdaq or Form4 in SEC. They sold only shares they purchased with their own money.
CEO and CFO still have more than 2 million share exposure.
Look at their compensation structure. They get paid almost 60% in stock and stock options. They have not sold those stocks yet.
SOFAR has not sold their shares, in fact increased. Aisling Capital, very very VERY close to TRXC. They have increased their position from 10 to 11mln shares as well.
Few sales of insider sales always happen. If they have cashed out entire or majority of their shares I would agree with you. However, there is nothing to read into here other than they invested personal capital and got them back out after major milestone was hit. Senhance approval by FDA. Anyway, in December there are 2 catalysts: EU sale announcement and 3mm instrument sales in EU.
Bears that are running naked will burn badly. Talk to you then!
Market Data 
Markets 
AI
